<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01575912</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A00047-36</org_study_id>
    <nct_id>NCT01575912</nct_id>
  </id_info>
  <brief_title>Past Pain Experience and Perception of Experimental Pain</brief_title>
  <official_title>Past Pain Experience and Perception of Experimental Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Esquirol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Esquirol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Differences in pain perception between subjects with and without psychiatric illness may be
      influenced by the individual experience, and not primarily by the pathology, although the
      pathological frame may amplify it.The aim of this study is to establish if the
      characteristics of experimental pain feeling are influenced by the past pain experience,
      anxiety and emotion, independently from the diagnosis. The pain experience will be evaluated
      by an inventory of the potentially painful situations that one can come across through the
      life, to determine the following points : Number of painful events in the past, number of
      painful points during the last 6 months, number of painful events lasting more than 6 months,
      sum of pain intensities (graduated with Visual Analogic Scale VAS from 0 to 10), sum of
      gravity (evaluated from 0 to 5), the category of pain experience qualification (mostly
      affective, mostly sensorial, or both).

      Schizophrenic, depressed and control participants will be recruited, and their pain
      experience throughout life will be put it in relation to experimental pain tests results
      (pressure application, ischemia induction), anxiety and emotion (Hospital Anxiety and
      Depression scale HAD), catastrophizing (Pain Catastrophizing Scale PCS), Heart Rate (HR)
      variation, Blood Pressure (BP) variation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The perception of moderated experimental pain (about 3 out of ten with visual analogue scale
      VAS) in subjects with schizophrenia (Girard et coll., 2011), major depression (ED) (bipolar
      or isolated/recurrent episode) (to be published) in comparison with controls without
      psychiatric pathologies show that exploration of pain in situation like medical examination
      to identify painful points should be done in the same conditions for persons with psychiatric
      troubles and persons without mental disease. But the risk is that the expression of pain,
      either in experimental conditions nor in the daily life, is not in relation with the feeling
      or perception of pain. Numerous factors may interfere in the pain message modulation, like
      the past pain experience, stress and anxiety, which are not or partially explored in
      experimental studies. The individual experience of pain is constructed throughout the whole
      life, from several influences (biological, psychological, and sociocultural). The symptoms
      interfaces of the different psychiatric troubles seem to be widely involved in the pain
      process, and its progressive construction. This study aims to better understand the
      relationships between all those variables.

      Procedures applied :

      Anterior pain experience evaluation (questionnaire); Pain tests : 160 kPa pressure
      application to determine corresponding pain with VAS), and ischemia induction to determine
      the time necessary to obtain a pain equivalent to 3 out of 10; anxiety and emotional
      evaluation (Hospital Anxiety and Depression scale), catastrophizing evaluation (Pain
      Catastrophizing Scale), HR variation and BP variation (vegetative measures linked to anxiety)
      collection of diagnosis, and therapeutic treatment
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale Evaluation for the Pre-fixed Pressure Test</measure>
    <time_frame>one month</time_frame>
    <description>pain tests will be realized during the first week of hospitalization for the persons hospitalized for major depression, and during the period of hospitalization (after stabilization) for the persons presenting schizophrenia.
The controls are tested within one month of the study information. total range : 0 - 10. The intensity of pain increases with the value of VAS. 10 corresponds to an unbearable pain.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">92</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Major Depression</condition>
  <arm_group>
    <arm_group_label>schizophrenia SC</arm_group_label>
    <description>subjects with a diagnosis of schizophrenia (SC) according to the DSM-IV-TR, submitted to experimental pain tests</description>
  </arm_group>
  <arm_group>
    <arm_group_label>major depression MD</arm_group_label>
    <description>subjects with a diagnosis of major depression (MD) according to the DSM-IV-TR, submitted to experimental pain tests</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls C</arm_group_label>
    <description>subjects without any diagnosis of psychiatric disorder (C) submitted to experimental pain tests</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>experimental pain tests</intervention_name>
    <arm_group_label>schizophrenia SC</arm_group_label>
    <arm_group_label>major depression MD</arm_group_label>
    <arm_group_label>controls C</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects hospitalized in the Esquirol Hospital center with schizophrenia or major
        depression according to the DSM-IV-TR criteria.

        Subjects without without known psychiatric history. Recruited persons will be matched
        according to age classes.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects with psychiatric trouble : diagnosis of schizophrenia or major depression
             according to the DSM-IV-TR criteria.

          -  control subjects : without known psychiatric history.

          -  age between 18 and 60.

        Exclusion Criteria:

          -  absence of consent, hospitalization under constraint, absence of health insurance.

          -  inability to answer the questionnaires

          -  pregnancy

          -  antalgic or analgesic treatment

          -  allergy to latex

          -  non stabilized high blood pressure, bad blood coagulation,

          -  peripheral neuropathy, nerve lesion, dermatosis at the superior extremities, muscular
             lesion or pathology at the upper member level

          -  non treated alcohol dependence

          -  illegal substance consumption in the past 48 hours

          -  participation to an other biomedical study during the 2 weeks before inclusion, and
             until the pain tests, if this study can interfere with the realization of the
             objectives
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Malauzat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Esquirol</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Esquirol</name>
      <address>
        <city>Limoges</city>
        <zip>87025</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Girard M, Plansont B, Bonnabau H, Malauzat D. Experimental pain hypersensitivity in schizophrenic patients. Clin J Pain. 2011 Nov-Dec;27(9):790-5. doi: 10.1097/AJP.0b013e31821d904c.</citation>
    <PMID>21593663</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2012</study_first_submitted>
  <study_first_submitted_qc>April 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2012</study_first_posted>
  <results_first_submitted>January 31, 2017</results_first_submitted>
  <results_first_submitted_qc>March 22, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 3, 2017</results_first_posted>
  <last_update_submitted>June 9, 2017</last_update_submitted>
  <last_update_submitted_qc>June 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Esquirol</investigator_affiliation>
    <investigator_full_name>Dominique Malauzat</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Schizophrenia</keyword>
  <keyword>Major depression</keyword>
  <keyword>Pain</keyword>
  <keyword>Past pain experience</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group of Subjects Presenting Schizophrenia SC</title>
          <description>subjects presenting a schizophrenia according to the DSM-IV-TR and submitted to experimental pain tests</description>
        </group>
        <group group_id="P2">
          <title>Group of Subjects Presenting Major Depression MD</title>
          <description>subjects presenting a major depression according to the DSM-IV-TR and submitted to experimental pain tests</description>
        </group>
        <group group_id="P3">
          <title>Group of Subjects Without Psychiatric Troubles C</title>
          <description>subjects without any psychiatric disorder and submitted to experimental pain tests</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group of Subjects With Schizophrenia SC</title>
          <description>subjects presenting a schizophrenia according to the DSM-IV-TR and submitted to experimental pain tests</description>
        </group>
        <group group_id="B2">
          <title>Group of Subjects Presenting Major Depression MD</title>
          <description>subjects presenting a major depression according to the DSM-IV-TR and submitted to experimental pain tests</description>
        </group>
        <group group_id="B3">
          <title>Group of Controls Without Psychiatric Disorder</title>
          <description>subjects without any psychiatric disorder and submitted to experimental pain tests</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="92"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.3" spread="9.72"/>
                    <measurement group_id="B2" value="44.69" spread="10.08"/>
                    <measurement group_id="B3" value="41.53" spread="10.27"/>
                    <measurement group_id="B4" value="43.21" spread="10.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale Evaluation for the Pre-fixed Pressure Test</title>
        <description>pain tests will be realized during the first week of hospitalization for the persons hospitalized for major depression, and during the period of hospitalization (after stabilization) for the persons presenting schizophrenia.
The controls are tested within one month of the study information. total range : 0 - 10. The intensity of pain increases with the value of VAS. 10 corresponds to an unbearable pain.</description>
        <time_frame>one month</time_frame>
        <population>analysis per arm group</population>
        <group_list>
          <group group_id="O1">
            <title>Group of Subjects Presenting Schizophrenia SC</title>
            <description>subjects presenting a schizophrenia according to the DSM-IV-TR and submitted to experimental pain tests</description>
          </group>
          <group group_id="O2">
            <title>Group of Subjects With Major Depression MD</title>
            <description>subjects presenting a major depression according to the DSM-IV-TR and submitted to experimental pain tests</description>
          </group>
          <group group_id="O3">
            <title>Group of Subjects Without Psychiatric Troubles C</title>
            <description>control subjects without any psychiatric disorder</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale Evaluation for the Pre-fixed Pressure Test</title>
          <description>pain tests will be realized during the first week of hospitalization for the persons hospitalized for major depression, and during the period of hospitalization (after stabilization) for the persons presenting schizophrenia.
The controls are tested within one month of the study information. total range : 0 - 10. The intensity of pain increases with the value of VAS. 10 corresponds to an unbearable pain.</description>
          <population>analysis per arm group</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="3.2"/>
                    <measurement group_id="O2" value="2.1" spread="1.8"/>
                    <measurement group_id="O3" value="1.2" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.121</p_value>
            <p_value_desc>using Mann Whitney test</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Group of Subjects With Schizophrenia SC</title>
          <description>subjects presenting a diagnosis of schizophrenia according to the DSM IV TR and submitted to experimental pain tests</description>
        </group>
        <group group_id="E2">
          <title>Group of Subjects Presenting Major Depression MD</title>
          <description>subjects presenting a diagnosis of major depression according to the DSM IV TR and submitted to experimental pain tests</description>
        </group>
        <group group_id="E3">
          <title>Group of Controls Without Psychiatric Disorder</title>
          <description>control subjects without any psychiatric disorder and submitted to experimental pain tests</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Murielle Girard</name_or_title>
      <organization>Centre Hospitalier Esquirol</organization>
      <phone>0033555431028</phone>
      <email>murielle.girard@ch-esquirol-limoges.fr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

